| OR (95% CI) | p value |
---|---|---|
Major postoperative morbidity | ||
Age (years) | Â | 0.029 |
 < 75 (ref.) |  |  |
 ≥ 75 | 1.62 (1.05–2.49) |  |
Sex | Â | 0.183 |
 Men (ref.) |  |  |
 Women | 0.76 (0.51–1.14) |  |
Location | Â | 0.293 |
 GEJ-SIII type (ref.) |  |  |
 Gastric | 0.67 (0.32–1.4) |  |
ASA score | Â | 0.24 |
 I–II (ref.) |  |  |
 III–IV | 1.28 (0.85–1.93) |  |
Neoadjuvant chemotherapy | Â | 0.065 |
 No (ref.) |  |  |
 Yes | 0.62 (0.38–1.03) |  |
Laparoscopic approach | Â | 0.005 |
 No (ref.) |  |  |
 Yes | 2.32 (1.29–4.17) |  |
Gastrectomy | Â | 0.005 |
 Distal subtotal (ref.) |  |  |
 Total | 1.86 (1.2–2.86) |  |
Lymphadenectomy | Â | 0.445 |
 D0–D1 (ref.) |  |  |
 D1+ or more | 0.84 (0.53–1.32) |  |
90-day postoperative mortality | ||
Age (years) | Â | 0.027 |
 < 75 (ref.) |  |  |
 ≥ 75 | 2.42 (1.15–5.29) |  |
ASA score | Â | 0.093 |
 I–II (ref.) |  |  |
 III–IV | 1.98 (0.89–4.39) |  |
Laparoscopic approach | Â | 0.495 |
 No (ref.) |  |  |
 Yes | 1.43 (0.51–3.97) |  |
Gastrectomy | Â | 0.769 |
 Distal subtotal (ref.) |  |  |
 Total | 0.89 (0.42–1.88) |  |
Pulmonay complications | Â | < 0.001 |
 No (ref.) |  |  |
 Yes | 8.54 (4.17–17.47) |  |
Cardiac complications | Â | < 0.001 |
 No (ref.) |  |  |
 Yes | 5.14 (2.09–12.61) |  |
Leakage | Â | 0.003 |
 No (ref.) |  |  |
 Yes | 3.56 (1.56–8.12) |  |
Hemorrhage | Â | 0.013 |
 No (ref.) |  |  |
 Yes | 5.1 (1.4–18.48) |  |
Reoperation | Â | 0.136 |
 No (ref.) |  |  |
 Yes | 1.99 (0.81–4.9) |  |